Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1681 of 5804
-
New hope for hard-to-treat prostate cancer: adding immunotherapy to current drug
Disease control OngoingThis phase II trial studies how well pembrolizumab works in treating patients with prostate cancer that has spread to other places in the body and keeps growing even when the amount of testosterone in the body is reduced to very low levels despite previous treatment with enzaluta…
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Drug shrinks skin cancer before surgery, may reduce cutting
Disease control CompletedOpen-label, non-comparative, multicenter, phase II study of Vismodegib in patients with locally advanced BCC.
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a virus trigger mental illness? new study investigates
Knowledge-focused Recruiting nowImmunology combined to neurobiology now offer prominent tools to yield biomarkers, so far missing in psychiatry, and to design innovative treatment approaches based on the discovery of new molecular and cellular targets. As Bipolar Disorder and Schizophrenia are now known to be s…
Phase: NA • Sponsor: Pr. Marion Leboyer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists hunt for early warning signs of Parkinson's
Knowledge-focused OngoingObservational, prospective, monocentric study to assess clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients and rate of progression compared to healthy controls (HC) and subjects at risk to develop PD. The primary objective of this study is to i…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Cannabinoid study reveals how the brain handles fear in PTSD
Knowledge-focused CompletedThe goal of this study is to look at how a type of drug called cannabinoids are related to the processing of fear signals, the experience of emotions and fear, and the pattern of activity in the brain that is involved in these processes and how this relates to the development of …
Phase: NA • Sponsor: Wayne State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New catheter lock could slash infection risk for cancer patients
Prevention CompletedThe purpose of this study is to compare the efficacy of a lock taurolidine-citrate solution vs standard saline solution for primary prevention of central venous catheter-associated bloodstream infection in adult patients treated with intra-venous therapy for a solid tumor
Phase: NA • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Could a common drug replace surgery for pituitary tumors?
Disease control OngoingDue to lack of hormone overproduction in non-functioning pituitary adenomas (NFPAs), only the symptomatic adenomas or large adenomas with proven growth and risk for symptoms in near future will undergo pituitary surgery. The remaining adenomas are monitored regularly. Operation o…
Phase: PHASE3 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug cocktail shows promise in Hard-to-Treat biliary cancers
Disease control OngoingThis is a phase II study (the second stage of testing a new drug or new drug combinations) to see how useful two different schedules of study drug selumetinib with cisplatin and gemcitabine are compared to cisplatin and gemticabine alone in patients with biliary cancer. Selumeti…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Prostate cancer detection may soon be as simple as a urine test
Diagnosis CompletedThis study is being conducted to collect and analyze biospecimens (blood and urine) and clinical data from patients with prostate cancer as well as healthy volunteers to better understand the differences between cancer cells and normal tissues with the goal of developing a better…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
No-Scalpel fix for swallowing disorder tracked in massive study
Disease control ENROLLING_BY_INVITATIONPOEM (Per-Oral endoscopic myotomy (creating a muscle \[esophagus\] opening), an incision-less (no cutting of the surface of the body) endoscopic procedure, is an effective non-surgical alternative to release the muscle \& sphincter of the LES for the treatment of achalasia.
Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Rare disease drug shows promise in reducing infections
Disease control CompletedBackground: \- WHIMS (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome) is a rare disease. It can cause cancers, infections, and warts. Researchers want to see if a drug called plerixafor can treat WHIMS. Objective: \- To compare plerixafor versus granulocy…
Phase: PHASE2, PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Two-Drug combo tested for tough thyroid cancer
Disease control OngoingThis randomized phase II trial studies the effects, good and bad, of using everolimus along with sorafenib tosylate versus sorafenib tosylate alone in treating patients with advanced radioactive iodine refractory thyroid cancer. Sorafenib tosylate and everolimus may stop the grow…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Lifesaving drug made available for rare fat disorder patients
Disease control OngoingBackground: \- Generalized lipodystrophy can cause high blood fat levels and resistance to insulin. This can lead to health problems including diabetes. Researchers have found that the drug metreleptin improves health in people with this disease. Objective: \- To test the safe…
Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug shows promise for Hard-to-Treat cancers with p53 gene
Disease control CompletedThis study evaluates the anti-tumor effects of ALRN-6924 in patients with advanced solid tumors or lymphomas with WT TP53.
Phase: PHASE1, PHASE2 • Sponsor: Aileron Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Oxygen therapy shows promise for stubborn diabetic foot sores
Disease control CompletedThe purpose of this study is to evaluate the efficacy, safety and economical benefits of Cyclical Pressure Topical Wound Oxygen (TWO2) Therapy in the treatment of chronic diabetic foot ulcers. Subjects will wear a standardized off-loading device and use advanced moist wound thera…
Phase: NA • Sponsor: AOTI Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Breathing low oxygen may spark nerve repair after spinal injury
Knowledge-focused Recruiting nowAccumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods (termed intermittent hypoxia) is a safe and effective treatment strategy to promote meaningful functional recovery in persons with chronic spinal cord injury (SCI). The goal of the study …
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Can a special diet calm your gut? new study tests food as medicine for Crohn's and colitis
Disease control OngoingThe study is proposed as a 2-year single site, open-label clinical trial of enteral nutrition or the specific carbohydrate diet in patients with active CD or UC. Patients seeking care in the outpatient clinics of the Division of Gastroenterology at Massachusetts General Hospital …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Brain surgery infection fighter: vancomycin powder put to the test
Disease control CompletedThis study is a collaboration between New York Presbyterian (NYP)-Columbia and NYP-Cornell that seeks to evaluate the use of topical vancomycin and its reduction on surgical site infection (SSI) in neurosurgical procedures. Adult patients undergoing neurosurgery at either institu…
Phase: PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Silent after surgery: new study hunts for clues to mysterious speech loss in kids
Knowledge-focused Recruiting nowThe purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Can less radiation be safer without sacrificing cancer control?
Disease control CompletedIn patients with squamous cell carcinoma of the oral cavity, the oropharynx and larynx with \>= pT3 and or pN+ postoperative radio - or radiochemotherapy is the standard of care. Postoperative radiochemotherapy is indicated in patients with multiple lymph node metastasis, lymph n…
Phase: PHASE2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC